βCD-(DIBO-Lys)7 was also used for co-delivery of anti-inflammatory superoxide dismutase (Sod) and catalase (Cat) by oral administration for the treatment of inflammatory bowel disease [84]. Here, CAT is linked to inflammatory bowel disease.